Approval · Notice of Compliance 19388 · 2017
IMRESTOR: Notice of Compliance 19388
Issued June 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19388
- Date
- June 7, 2017
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing changes
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMRESTOR | 02452820 | Dormant |
Medicinal ingredients
- PEGBOVIGRASTIM 15 MG per 2.7ML